Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros











Intervalo de año de publicación
1.
Animal Model Exp Med ; 7(3): 195-207, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38808561

RESUMEN

Glaucoma, an irreversible optic neuropathy, primarily affects retinal ganglion cells (RGC) and causes vision loss and blindness. The damage to RGCs in glaucoma occurs by various mechanisms, including elevated intraocular pressure, oxidative stress, inflammation, and other neurodegenerative processes. As the disease progresses, the loss of RGCs leads to vision loss. Therefore, protecting RGCs from damage and promoting their survival are important goals in managing glaucoma. In this regard, resveratrol (RES), a polyphenolic phytoalexin, exerts antioxidant effects and slows down the evolution and progression of glaucoma. The present review shows that RES plays a protective role in RGCs in cases of ischemic injury and hypoxia as well as in ErbB2 protein expression in the retina. Additionally, RES plays protective roles in RGCs by promoting cell growth, reducing apoptosis, and decreasing oxidative stress in H2O2-exposed RGCs. RES was also found to inhibit oxidative stress damage in RGCs and suppress the activation of mitogen-activated protein kinase signaling pathways. RES could alleviate retinal function impairment by suppressing the hypoxia-inducible factor-1 alpha/vascular endothelial growth factor and p38/p53 axes while stimulating the PI3K/Akt pathway. Therefore, RES might exert potential therapeutic effects for managing glaucoma by protecting RGCs from damage and promoting their survival.


Asunto(s)
Glaucoma , Fármacos Neuroprotectores , Resveratrol , Células Ganglionares de la Retina , Resveratrol/farmacología , Resveratrol/uso terapéutico , Células Ganglionares de la Retina/efectos de los fármacos , Glaucoma/tratamiento farmacológico , Animales , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Estrés Oxidativo/efectos de los fármacos
2.
Front Neurol ; 13: 944791, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36247795

RESUMEN

Migraine headaches are highly prevalent, affecting 15% of the population. However, despite many studies to determine this disease's mechanism and efficient management, its pathophysiology has not been fully elucidated. There are suggested hypotheses about the possible mediating role of mast cells, immunoglobulin E, histamine, and cytokines in this disease. A higher incidence of this disease in allergic and asthma patients, reported by several studies, indicates the possible role of brain mast cells located around the brain vessels in this disease. The mast cells are more specifically within the dura and can affect the trigeminal nerve and cervical or sphenopalatine ganglion, triggering the secretion of substances that cause migraine. Neuropeptides such as calcitonin gene-related peptide (CGRP), neurokinin-A, neurotensin (NT), pituitary adenylate-cyclase-activating peptide (PACAP), and substance P (SP) trigger mast cells, and in response, they secrete pro-inflammatory and vasodilatory molecules such as interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) as a selective result of corticotropin-releasing hormone (CRH) secretion. This stress hormone contributes to migraine or intensifies it. Blocking these pathways using immunologic agents such as CGRP antibody, anti-CGRP receptor antibody, and interleukin-1 beta (IL-1ß)/interleukin 1 receptor type 1 (IL-1R1) axis-related agents may be promising as potential prophylactic migraine treatments. This review is going to summarize the immunological aspects of migraine.

3.
Hematol., Transfus. Cell Ther. (Impr.) ; 44(4): 504-511, Oct.-dec. 2022. tab, graf, ilus
Artículo en Inglés | LILACS | ID: biblio-1421536

RESUMEN

ABSTRACT Background: Hematopoietic stem/progenitor cell transplantation is the main treatment option for hematological malignancies and disorders. One strategy to solve the problem of low stem cell doses used in transplantation is pre-transplant expansion. We hypothesized that using fibronectin-coated microfluidic channels would expand HSPCs and keep self-renewal potential in a three-dimensional environment, compared to the conventional method. We also compared stem cell homing factors expression in microfluidic to conventional cultures. Materials and methods: A microfluidic device was created and characterized by scanning electron microscopy. The CD133+ cells were collected from cord blood and purified. They were subsequently cultured in 24-well plates and microfluidic bioreactor systems using the StemSpan serum-free medium. Eventually, we analyzed cell surface expression levels of the CXCR4 molecule and CXCR4 mRNA expression in CD133+ cells cultured in different systems. Results: The expansion results showed significant improvement in CD133+ cell expansion in the microfluidic system than the conventional method. The median expression of the CXCR4 in the expanded cell was lower in the conventional system than in the microfluidic system. The CXCR4 gene expression up-regulated in the microfluidic system. Conclusion: Utilizing microfluidic systems to expand desired cells effectively is the next step in cell culture. Comparative gene expression profiling provides a glimpse of the effects of culture microenvironments on the genetic program of HSCs grown in different systems.


Asunto(s)
Fibronectinas , Enfermedades Hematológicas , Células Madre Neoplásicas , Células Madre Hematopoyéticas , Neoplasias Hematológicas , Reactores Biológicos , Receptores CXCR4 , Sangre Fetal
4.
Iran J Basic Med Sci ; 25(2): 148-154, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-35655592

RESUMEN

Objectives: Calcium dobesilate (CaD) has anti-oxidant, anti-inflammatory, and anti-apoptotic effects. In this study, the protective effects of CaD against hepatorenal damage induced by carbon tetrachloride (CCl4) in mice were evaluated. Materials and Methods: Thirty male mice were randomly divided into five groups: Control, CaD 100 mg/kg, CCl4, CCl4+CaD 50 mg/kg, and CCl4+CaD 100 mg/kg. CaD (50 and 100 mg/kg) was administered orally once a day for 4 weeks. The liver and kidney indices (serum creatinine, blood urine nitrogen, alanine aminotransferase, and aspartate aminotransferase levels) were determined. Also, liver and kidney tissue oxidant/anti-oxidant markers (glutathione peroxidase, malondialdehyde, total anti-oxidant capacity, and superoxide dismutase) were measured. Cleaved caspase-3, Bax, cytochrome-c, and Bcl-2 protein levels were measured by immunoblotting method in the liver and kidney tissues. The liver and kidney histopathological changes were evaluated by the Hematoxylin and Eosin (H&E) staining method. Results: CCl4 induced significant oxidative stress and apoptosis in kidney and liver tissues that was concomitant with histopathological abnormalities in these organs in the CCl4 group versus the control (P<0.05). However, CaD (100 mg/kg) could significantly improve the histopathological change in the liver and kidney tissues of CCl4+CaD 100 mg/kg mice versus the CCl4 group (P<0.05). In addition, CaD (100 mg/kg) attenuated the pro and anti-apoptotic markers in the liver and kidney tissues of CCl4+CaD 100 mg/kg mice versus the CCl4 group (P<0.05). Conclusion: CaD (100 mg/kg) has a protective effect against hepatorenal injury induced by CCl4 at least via its anti-apoptotic and anti-oxidant properties.

5.
Mol Biol Rep ; 49(3): 1763-1771, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35020122

RESUMEN

BACKGROUND: Acetaminophen overdose causes renal injury via oxidative stress and apoptosis induction. Carvacrol has several pharmacological properties such as antioxidant, anti-inflammation and anti-apoptotic effect. The aim of this study was to determine the protective effect of carvacrol on acetaminophen-induced renal damage in rats. METHODS AND RESULTS: Forty male Wistar rats were randomly divided to five groups (n = 8) including control, carvacrol 10 mg/kg, acetaminophen, acetaminophen + carvacrol 5 mg/kg, and acetaminophen + carvacrol 10 mg/kg. Animals received a single dose of acetaminophen (500 mg/kg), then were treated with carvacrol for 1 week (daily). Afterwards, renal blood flow (RBF), mean arterial pressure, renal perfusion pressure, renal vascular resistance (RVR), blood urea nitrogen (BUN), and serum creatinine were measured. Also, malondialdehyde (MDA) concentration, glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity levels were measured in the kidney tissue. Hematoxylin and eosin method was used for histological assessment. The Western blotting analysis was used to determine the Bax, Bcl-2 and cleaved caspase-3 proteins expression level in the kidney tissue. Carvacrol (10 mg/kg) significantly increased the RBF, GPx and SOD activities and also reduced the RVR, serum creatinine, BUN, and MDA in the acetaminophen + carvacrol 10 mg/kg group versus acetaminophen group (P < 0.05). Also, carvacrol significantly decreased the cleaved caspase-3, Bax proteins expression level, and kidney tissue damage score in the acetaminophen + carvacrol 10 mg/kg group versus acetaminophen group (P < 0.05). CONCLUSIONS: This study showed that carvacrol can attenuate the acetaminophen induced acute kidney damage via suppressing oxidative stress and apoptosis biochemical factors.


Asunto(s)
Acetaminofén , Riñón , Acetaminofén/efectos adversos , Animales , Apoptosis , Cimenos , Riñón/metabolismo , Masculino , Malondialdehído/metabolismo , Estrés Oxidativo , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo
6.
Hematol Transfus Cell Ther ; 44(4): 504-511, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34593367

RESUMEN

BACKGROUND: Hematopoietic stem/progenitor cell transplantation is the main treatment option for hematological malignancies and disorders. One strategy to solve the problem of low stem cell doses used in transplantation is pre-transplant expansion. We hypothesized that using fibronectin-coated microfluidic channels would expand HSPCs and keep self-renewal potential in a three-dimensional environment, compared to the conventional method. We also compared stem cell homing factors expression in microfluidic to conventional cultures. MATERIALS AND METHODS: A microfluidic device was created and characterized by scanning electron microscopy. The CD133+ cells were collected from cord blood and purified. They were subsequently cultured in 24-well plates and microfluidic bioreactor systems using the StemSpan serum-free medium. Eventually, we analyzed cell surface expression levels of the CXCR4 molecule and CXCR4 mRNA expression in CD133+ cells cultured in different systems. RESULTS: The expansion results showed significant improvement in CD133+ cell expansion in the microfluidic system than the conventional method. The median expression of the CXCR4 in the expanded cell was lower in the conventional system than in the microfluidic system. The CXCR4 gene expression up-regulated in the microfluidic system. CONCLUSION: Utilizing microfluidic systems to expand desired cells effectively is the next step in cell culture. Comparative gene expression profiling provides a glimpse of the effects of culture microenvironments on the genetic program of HSCs grown in different systems.

7.
Life Sci ; 258: 118119, 2020 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-32682915

RESUMEN

Ceftriaxone (CTX) is a third-generation cephalosporin antibiotic that has broad-spectrum antimicrobial activity. This agent also has anti-inflammatory and antioxidant characteristics. In the current study, the effects of CTX against hepatorenal damages in a D-galactose (DGL) induced aging model were investigated. We used twenty-eight male mice which equally and randomly were separated into four groups as follows: Control, DGL group (treated with 500 mg/kg/day DGL orally for six weeks), DGL + CTX group (treated with 500 mg/kg/day DGL orally plus 200 mg/kg/day CTX intraperitoneally for six weeks), and CTX group (treated with 200 mg/kg/day CTX intraperitoneally for six weeks). The liver and kidney function indices such as serum creatinine, blood urine nitrogen, alanine aminotransferase, and aspartate aminotransferase were measured. Also, levels of malondialdehyde, catalase, and glutathione peroxidase in hepatic and renal tissues were evaluated. Moreover, the expression profiles of interleukin 1 beta and tumor necrosis factor alpha were assessed. The liver and kidney tissues were assessed for histopathological lesions. The results showed that aging induced by DGL leads to abnormalities in functional indices of the liver and kidneys. DGL also induced significant oxidative stress and inflammation, as well as histopathological lesions, in these organs. CTX improved functional indices, as well as the parameters of oxidative stress and inflammation, compared with the DGL-treated animals. These results were also confirmed by histological evaluations of the liver and kidneys. These data provide evidence for the therapeutic value of CTX in clinical practice for mitigating the hepatorenal damages of aging.


Asunto(s)
Envejecimiento/patología , Ceftriaxona/uso terapéutico , Síndrome Hepatorrenal/tratamiento farmacológico , Animales , Ceftriaxona/farmacología , Galactosa , Inflamación/patología , Riñón/efectos de los fármacos , Riñón/patología , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Ratones , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos
8.
ISA Trans ; 96: 177-184, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31285061

RESUMEN

This paper introduces a continuous-time fractional-order Hammerstein state-space model with a systematic identification algorithm for modeling nonlinear dynamic systems. The proposed model consists of a radial-basis function neural network followed by a fractional-order system. The proposed identification scheme is accomplished in two stages. The structural parameters of the fractional-order system (i.e. the values of the fractional order and the degree of the denominator in the fractional-order system) are estimated in the frequency domain. Then, the synaptic weights of the radial-basis function neural network and the coefficients of the fractional-order system are determined in the time domain via the Lyapunov stability theory, which guarantees stability of the given method and its convergence under a mild condition. Three examples are provided to show the effectiveness of the proposed method.

9.
Mol Biol Rep ; 47(2): 1371-1379, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31873871

RESUMEN

Unilateral ureteral obstruction (UUO) induces kidney injury. Oleuropein as a major compound of olive leaves modulates the inflammatory parameters and decreases oxidative stress. Accordingly, we evaluate the renoprotective effect of oleuropein against 3-day UUO rats. Forty rats were randomly divided into five groups (n = 8) including control, UUO and UUO + oleuropein groups (50, 100 and 200 mg/kg). UUO model was induced by left ureter ligation and continued for 3-day. Rats were treated synchronic daily for 3-day, then mean arterial pressure (MAP), renal perfusion pressure (RPP), renal blood flow (RBF), serum creatinine level, and also superoxide dismutase (SOD), glutathione peroxidase (GPx) activity levels and malondialdehyde (MDA) concentration (in the obstructed kidney) were measured. The western blotting method was applied to evaluate the Bax, Bcl-2, cleaved caspase-3 and TNF-α proteins expression level. The hematoxylin and eosin method was applied to evaluate the kidney tissue damage score (KTDS). UUO significantly increased RVR, KTDS, and MDA, cleaved caspase-3, Bax, serum creatinine and TNF-α protein levels (P < 0.05), and also significantly decreased RBF, SOD, and GPx and Bcl-2 protein expression levels (P < 0.001) in the obstructed kidney and oleuropein (200 mg/kg) significantly ameliorated the changes induced by UUO. Our findings showed that oleuropein has a renoprotective effect against 3-day UUO. The mechanisms underlying the observed effects may be related to its antioxidative stress, anti-apoptotic, and anti-inflammatory effects.


Asunto(s)
Apoptosis , Inflamación/complicaciones , Iridoides/uso terapéutico , Riñón/lesiones , Estrés Oxidativo , Obstrucción Ureteral/tratamiento farmacológico , Obstrucción Ureteral/patología , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Creatinina/sangre , Glutatión Peroxidasa/metabolismo , Hemodinámica , Glucósidos Iridoides , Iridoides/administración & dosificación , Iridoides/química , Iridoides/farmacología , Riñón/efectos de los fármacos , Riñón/patología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Superóxido Dismutasa/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Proteína X Asociada a bcl-2/metabolismo
10.
Iran J Basic Med Sci ; 22(9): 1097-1101, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31807255

RESUMEN

OBJECTIVES: Previous studies have indicated that phytoestrogens induce estrogenic as well as anti-inflammatory effects, and they are found in high abundance in the extracts of some herbs such as Vitex Agnus Castus (VAC). Therefore, we investigated the effect of VAC extract on ovariectomized mice after the induction of permanent middle cerebral artery occlusion (PMCAO) model. MATERIALS AND METHODS: In this study, 50 mice ranging from 25 to 35 g were divided into five experimental groups as follows: Control, VAC, Estrogen, Tamoxifen, and Tamoxifen-VAC. Animals were ovariectomized, and after 30 days of treatment, they were given PMCAO induction. Behavioral assessment (adhesive removal and wire hanging tests) was evaluated 24 hr, 48 hr, and one week after induction of stroke. The infarct volume, as well as serum levels of matrix metalloproteinase-9 (MMP-9) and interleukin-10 (IL-10), were measured one week after stroke. RESULTS: One week after stroke, in both VAC and estrogen groups, the infarct size reduced in comparison with the control group. Estrogen and VAC extract improved adhesive removal and wire hanging test, increased the level of IL-10, and decreased the level of MMP-9 compared with the control group. In addition, co-administration of tamoxifen and VCA extract had no significant effect on measured indices compared with control and tamoxifen groups. CONCLUSION: Based on our findings, VAC extract has neuroprotective properties and can reduce stroke injuries in PMCAO-induced ovariectomized mice via anti-inflammatory and estrogenic properties.

11.
Clin Exp Pharmacol Physiol ; 46(12): 1133-1140, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31357227

RESUMEN

Health promotion and healthy nutrition significantly increased life expectancy around the world. Aging is associated with an increase in age-related diseases. The use of metformin (Met) as an anti-aging drug has recently been proposed based on its widespread use in clinical practice. Reports have shown that Met acts as an anti-aging agent. In this study, the effects of long-term, 1 year, Met administration on aging-related behaviors and longevity in ovariectomized mice was studied. Met (1 and 10 mg/kg, daily) was administered orally in ovariectomized mice. The anxiety-like behavior, working memory, and physical strength were measured through elevated plus maze, Y-maze, vertical grid holding, and the obligatory swimming capacity tests. Brains were harvested to measure brain-derived neurotrophic factor (BDNF) level. Also, the Kaplan-Meier survival curves were used to show differences and similarities in survival patterns. Met (10 mg/kg) decreased anxiety-like behaviors as well as increased muscle strength and working memory in the ovariectomized mice. Moreover, Met increased the physical strength and longevity as well as the level of BDNF in the ovariectomized mice. Our results indicate that Met administration can be an effective strategy for having a healthy aging in the absence of female gonadal hormones and reverses deleterious effects of ovariectomy-induced aging possibly through BDNF.


Asunto(s)
Envejecimiento/efectos de los fármacos , Cognición/efectos de los fármacos , Metformina/farmacología , Sarcopenia/prevención & control , Envejecimiento/fisiología , Envejecimiento/psicología , Animales , Ansiedad/tratamiento farmacológico , Ansiedad/patología , Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/fisiología , Modelos Animales de Enfermedad , Esquema de Medicación , Femenino , Aprendizaje por Laberinto/efectos de los fármacos , Memoria a Corto Plazo/efectos de los fármacos , Metformina/administración & dosificación , Ratones , Ovariectomía , Factores de Tiempo
12.
Naunyn Schmiedebergs Arch Pharmacol ; 392(11): 1383-1391, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31236657

RESUMEN

Oleuropein, as an olive leaf extract antioxidant polyphenol, has been reported to be a free radical scavenger. This study was done to investigate the effects of oleuropein, against morphine-induced hippocampus neurotoxicity and memory impairment in rats. The Morris water maze (MWM) test was used to assess the effect of oleuropein (5, 15, and 30 mg/kg, i.p., co-administrated with morphine) on spatial learning and memory of male Wistar rats which were treated with morphine sulfate (45 mg/kg, s.c., 4 weeks). In order to evaluate the cleaved caspase-3, Bax, and Bcl2 protein expression (as biochemical markers of apoptosis) in CA1 area of hippocampus tissue, the western blot test was used. Also, to evaluate the oxidative stress status of hippocampus CA1 area tissue, the malondialdehyde (MDA) level, superoxide dismutase (SOD) activity, and glutathione peroxidase (GPx) activity were assessed. The data showed that oleuropein treatment (15 and 30 mg/kg) improves the spatial learning and memory impairments in morphine-treated animals. Also, oleuropein treatment decreased the apoptosis and oxidative stress levels in the hippocampus CA1 area of morphine-treated rats. Oleuropein can prevent the spatial learning and memory impairments in morphine-treated rats. Molecular mechanisms underlying the observed effects could be at least partially related to the inhibition of neuronal apoptosis and oxidative stress in the hippocampus CA1 area of morphine-treated rats.


Asunto(s)
Antioxidantes/farmacología , Región CA1 Hipocampal/efectos de los fármacos , Iridoides/farmacología , Trastornos de la Memoria/prevención & control , Morfina/toxicidad , Síndromes de Neurotoxicidad/prevención & control , Animales , Región CA1 Hipocampal/enzimología , Glutatión Peroxidasa/metabolismo , Glucósidos Iridoides , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Síndromes de Neurotoxicidad/metabolismo , Síndromes de Neurotoxicidad/patología , Síndromes de Neurotoxicidad/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Aprendizaje Espacial/efectos de los fármacos , Superóxido Dismutasa/metabolismo
13.
Inflammation ; 41(6): 2052-2059, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30047001

RESUMEN

Administration of tissue plasminogen activator (tPA) during first 3-4.5 h after ischemic stroke is the main therapeutic strategy; however, its using after that, leads to reperfusion injury and neurotoxic effects. Additionally, inflammation has a critical role in secondary injury after late reperfusion therapy. Thus, this project was designed to explore the effects of JZL-184 (JZL), an agonist of type 1 cannabinoid receptor (CB1), on the side effects of recombinant tPA (r-tPA), which is administrated after 5 h of stroke onset in the mice middle cerebral artery occlusion (MCAO) model. After established the model of MCAO mouse, they were put to six groups, including intact, control, vehicle, JZL (4 mg/kg), r-tPA (9 mg/kg), and JZL plus r-tPA. Thereafter, brain levels of IL-10, TNF-α, and matrix metalloproteinase - 9 (MMP9), brain edema and infarction, and behavioral functions have been determined in the groups. JZL alone or in combination with r-tPA, but not r-tPA, reduced brain edema, infarct volume, brain levels of TNF-α, MMP9, and also improved behavioral tests. JZL and JZL plus r-tPA also increased brain levels of IL-10. According to the results, JZL can improve the effects of r-tPA to overcome stroke SSE, when used after 5 h of stroke onset. Based on the fact that there is limitation regarding using r-tPA after 3 h of stroke onset, using a combination of r-tPA/JZL can be considered for a future therapeutic strategy.


Asunto(s)
Benzodioxoles/farmacología , Quimioterapia Combinada/métodos , Monoacilglicerol Lipasas/antagonistas & inhibidores , Piperidinas/farmacología , Accidente Cerebrovascular/tratamiento farmacológico , Activador de Tejido Plasminógeno/farmacología , Animales , Benzodioxoles/uso terapéutico , Sinergismo Farmacológico , Inhibidores Enzimáticos/uso terapéutico , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Ratones , Piperidinas/uso terapéutico , Factores de Tiempo
14.
Biomed Pharmacother ; 103: 1720-1726, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29864962

RESUMEN

INTRODUCTION: Stroke is a prevalent disorder which is associated with several complications including inflammation. JZL-184 (JZL) inhibits arachidonic acid (AA) production and consequently results in two-arachidonoylglycerol (2-AG) accumulation. Both reduced production of AA metabolic products and increased 2-AG, the agonist of type 1 cannabinoid receptor (CB1), can result in reduced inflammation. In this study, we investigated the mechanisms of JZL in the improvement of stroke complications in mouse permanent cerebral ischemia (PPMCAO) model using AM251, the antagonist of CB1. MATERIAL AND METHODS: PMCAO mice were divided into six groups including intact, controls, vehicle, JZL, AM251 and JZL plus AM251 administrated groups. Brain infarction and edema, brain levels of matrix metalloperoteinase-9 (MMP9), interleukin (IL)-10 and tumor necrosis factor-α (TNF-α) and behavioral functions have been examined in all groups. RESULTS: The results showed that JZL lowered brain infarction, neurological disorders, TNF-α and MMP9 more effectively than JZL plus AM251. JZL and JZL plus AM251 reduced brain edema and increased brain IL-10. JZL, AM251 and JZL plus AM251 improve behavioral functions. DISCUSSION: JZL reduces brain infarction and brain pro-inflammatory molecules in CB1 pathway dependent manner. JZL also reduces brain edema and increased IL-10 in CB1 pathways or decreased AA metabolites. Further, AM251 improves behavioral functions via unknown mechanisms.


Asunto(s)
Benzodioxoles/farmacología , Cannabinoides/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Inflamación/patología , Monoacilglicerol Lipasas/antagonistas & inhibidores , Piperidinas/farmacología , Transducción de Señal/efectos de los fármacos , Animales , Benzodioxoles/uso terapéutico , Edema Encefálico/complicaciones , Edema Encefálico/tratamiento farmacológico , Edema Encefálico/enzimología , Edema Encefálico/patología , Infarto Encefálico/complicaciones , Infarto Encefálico/tratamiento farmacológico , Infarto Encefálico/enzimología , Infarto Encefálico/patología , Inflamación/complicaciones , Inflamación/tratamiento farmacológico , Interleucina-10/metabolismo , Masculino , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Monoacilglicerol Lipasas/metabolismo , Piperidinas/uso terapéutico , Pirazoles/farmacología , Pirazoles/uso terapéutico , Factor de Necrosis Tumoral alfa/metabolismo
15.
Life Sci ; 198: 143-148, 2018 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-29496497

RESUMEN

INTRODUCTION: Investigators are searching to find new therapeutic strategies to reduce stroke secondary injury. JZL-184 (JZL) is an inhibitory factor for production of arachidonic acid (AA). Thus, it suppresses production of AA metabolites which are the cause of inflammation and tissue edema. Therefore, JZL may be considered for suppression of stroke secondary injury in mice middle cerebral artery occlusion (MCAO) model. Additionally, Aspirin is a known anti-inflammatory factor which is used to reduce pro-inflammatory secondary injury. The aim of this study was to determine the effects of JZL on the reduction of stroke secondary injury and to compare them with Aspirin effects. MATERIAL AND METHODS: MCAO model has been induced and accordingly 83 male MCAO induced mice have been introduced to the study. The animals were divided to seven groups including intact, controls, vehicle, Aspirin, JZL 4, 8 and 16 mg/kg administrated groups. Brain edema and infarction, behavioral functions and brain levels of IL-10, TNF-α and matrix metaloperoteinase-9 (MMP9) have been examined in the evaluated groups. RESULTS: The results revealed that JZL reduced brain edema, infarction, brain levels of TNF-α and MMP9 and also increased brain levels of IL-10 as well as improved behavioral functions in all three concentrations. The therapeutic effects of JZL were observed as well as Aspirin. DISCUSSION: Based on the results, it seems that JZL can be considered as a good candidate for inhibition of stroke secondary injury in the case of delayed treatment.


Asunto(s)
Benzodioxoles/farmacología , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Monoacilglicerol Lipasas/antagonistas & inhibidores , Fármacos Neuroprotectores/farmacología , Piperidinas/farmacología , Accidente Cerebrovascular/tratamiento farmacológico , Animales , Aspirina/farmacología , Conducta Animal , Encéfalo/metabolismo , Edema Encefálico/patología , Isquemia Encefálica/tratamiento farmacológico , Modelos Animales de Enfermedad , Edema/patología , Infarto de la Arteria Cerebral Media/complicaciones , Inflamación , Interleucina-10/metabolismo , Masculino , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Monoacilglicerol Lipasas/metabolismo , Accidente Cerebrovascular/complicaciones , Factor de Necrosis Tumoral alfa/metabolismo
16.
Behav Brain Res ; 334: 55-60, 2017 09 15.
Artículo en Inglés | MEDLINE | ID: mdl-28750834

RESUMEN

Atorvastatin (Ator), competitive inhibitors of 3-hydroxymethyl-3-glutaryl-coenzyme-A reductase, is a cholesterol lowering drug. Ator has been shown to have neuroprotective, antioxidant and anti-inflammatory properties making that a potential candidate for the treatment of central nervous system (CNS) disorders. Here we assessed the effect of Ator on the d-galactose (d-gal)-induced aging in mice. For this purpose, Ator (0.1 and 1mg/kg/p.o.), was administrated daily in d-gal-received (500mg/kg/p.o.) mice model of aging for six weeks. Anxiety-like behaviors and cognitive functions were evaluated by the elevated plus-maze and novel object recognition tasks, respectively. Physical power was assessed by forced swimming capacity test. Animals brains were analyzed for the superoxide dismutase (SOD) and brain-derived neurotrophic factor (BDNF). We found that Ator decreases the anxiety-like behaviors in d-gal-treated mice. Also, our behavioral tests showed that Ator reverses the d-gal induced learning and memory impairment. Furthermore, we found that Ator increases the physical power of d-gal-treated mice. Our results indicated that the neuroprotective effect of Ator on d-gal induced neurotoxicity is mediated, at least in part, by an increase in the SOD and BDNF levels. The results of present study suggest that Ator could be used as a novel therapeutic strategy for the treatment of age-related conditions.


Asunto(s)
Envejecimiento/efectos de los fármacos , Antioxidantes/farmacología , Atorvastatina/farmacología , Encéfalo/efectos de los fármacos , Nootrópicos/farmacología , Envejecimiento/metabolismo , Envejecimiento/patología , Animales , Ansiedad/tratamiento farmacológico , Ansiedad/metabolismo , Ansiedad/patología , Encéfalo/metabolismo , Encéfalo/patología , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Cognición/efectos de los fármacos , Cognición/fisiología , Relación Dosis-Respuesta a Droga , Galactosa , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Ratones , Modelos Animales , Distribución Aleatoria , Reconocimiento en Psicología/efectos de los fármacos , Reconocimiento en Psicología/fisiología , Superóxido Dismutasa/metabolismo
17.
Can J Physiol Pharmacol ; 95(6): 708-713, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28187266

RESUMEN

In the current study, the effects of troxerutin (TRX) on muscle fatigue and gene expression of Bcl-2 and Bax in the hepatic tissue of rats was investigated. Forty male Wistar rats were randomly divided into 4 groups and designated as control and TRX treatment at 75 (TRX75), 150 (TRX150), and 300 mg/kg per day (TRX300). The treated groups and control group received TRX and water orally for 7 days. After an exhaustive swimming test on the 7th day, all animals were euthanized immediately and several biochemical parameters related to fatigue and gene expression of Bcl-2 and Bax in the hepatic tissue were measured. Our results showed that the exhaustion swimming time in the TRX300 groups significantly increased 1.2-fold compared with the control group (P < 0.001). TRX300 significantly reduced ALT (P < 0.05) activity and increased liver SOD activity compared with the control group (P < 0.01). Additionally, TRX significantly reduced the liver mRNA expressions of Bax (P < 0.001) and increased the Bcl-2/Bax ratio (P < 0.001) compared with the control group. Based on our data, TRX possesses anti-apoptotic and hepatoprotective action following exhaustive swimming exercise.


Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , Hidroxietilrutósido/análogos & derivados , Hígado/efectos de los fármacos , Hígado/metabolismo , Fatiga Muscular/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteína X Asociada a bcl-2/genética , Animales , Apoptosis/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glutatión Peroxidasa/metabolismo , Hidroxietilrutósido/farmacología , Hígado/citología , Masculino , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Natación , Proteína X Asociada a bcl-2/metabolismo
18.
Cent Eur J Immunol ; 41(1): 54-63, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27095923

RESUMEN

INTRODUCTION: Chronic pancreatitis (CP) is an intractable and multi-factorial disorder. Developing appropriate animal models is an essential step in pancreatitis research, and the best ones are those which mimic the human disorder both aetiologically and pathophysiologically. The current study presents an optimised protocol for creating a murine model of CP, which mimics the initial steps of chronic pancreatitis in alcohol chronic pancreatitis and compares it with two other mouse models treated with cerulein or ethanol alone. MATERIAL AND METHODS: Thirty-two male C57BL/6 mice were randomly selected, divided into four groups, and treated intraperitoneally with saline (10 ml/kg, control group), ethanol (3 g/kg; 30% v/v), cerulein (50 µg/kg), or ethanol + cerulein, for six weeks. Histopathological and immunohistochemical assays for chronic pancreatitis index along with real-time PCR assessments for mRNA levels of inflammatory cytokines and fibrogenic markers were conducted to verify the CP induction. RESULTS: The results indicated that CP index (CPI) was significantly increased in ethanol-cerulein mice compared to the saline, ethanol, and cerulein groups (p < 0.001). Interleukin 1ß (IL-1ß), tumor necrosis factor α (TNF-α), transforming growth factor ß (TGF-ß), α-smooth muscle actin (α-SMA), and myeloperoxidase activity were also significantly greater in both cerulein and ethanol-cerulein groups than in the saline treated animals (p < 0.001). Immunohistochemical analysis revealed enhanced expression of TGF-ß and α-SMA in ethanol-cerulein mice compared to the saline group. CONCLUSIONS: Intraperitoneal (IP) injections of ethanol and cerulein could successfully induce CP in mice. IP injections of ethanol provide higher reproducibility compared to ethanol feeding. The model is simple, non-invasive, reproducible, and time-saving. Since the protocol mimics the initial phases of CP development in alcoholics, it can be used for investigating basic mechanisms and testing new therapies.

19.
Adv Pharm Bull ; 4(Suppl 1): 437-41, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25364659

RESUMEN

PURPOSE: Accumulating evidence indicates that glycyrrhizin (GZ) and its hydrolyzed metabolite 18-ß glycyrrhetinic acid (GA) exhibit anti-inflammatory and anticancer activities. The objective of this study was to examine the in vitro cytotoxic activity of GA on human ovarian cancer A2780 cells. METHODS: A2780 cells were cultured in RPMI1640 containing 10% fetal bovine serum. Cells were treated with different doses of GA and cell viability and proliferation were detected by dye exclusion and 3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assays. Apoptosis induction and expression of Fas and Fas ligand (FasL) were analyzed by flow cytometry. RESULTS: We observed that GA decreases cell viability and suppressed cells proliferation in a dose-dependent manner as detected by dye-exclusion and XTT assayes. In addition, our flow cytometry data show that GA not only induces apoptosis in A2780 cells but also upregulates both Fas and FasL on these cells in a dose-dependent manner. CONCLUSION: we demonstrate that GA causes cell death in A2780 cells by inducing apoptosis.

20.
Iran J Basic Med Sci ; 16(2): 129-33, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24298379

RESUMEN

OBJECTIVE(S): In our previous study, we reported that capsaicin-induced unmyelinated C-fiber depletion can modulate excitatory and integrative circuits in the somatosensory cortex following experience-dependent plasticity. In this study, we investigated the involvement of the capsaicin-induced acute inactivation of c-fibers on tactile learning in rat. MATERIALS AND METHODS: The delayed novel object recognition test was used to assess tactile learning. This procedure consisted of two phases. The first of these (T1) was a training phase during which the animals explored two similar objects. T2, the test phase, occurred 24 hr later, during which the animals explored one novel and one familiar object. In order to induce acute inactivation of the C-fiber pathway, 25-30 µl of a 10% capsaicin was injected subcutaneously into the rat's upper lip, 6 h prior to T1. Tactile learning was quantified using a discrimination ratio. RESULTS: In T2, the discrimination ratio in capsaicin-treated animals (37.3±3.8%) was lower than that observed in vehicle-treated animals (54.4±5.1%, P<0.05). CONCLUSION: These findings indicate that the selective inactivation of a peripheral nociceptor subpopulation affects tactile learning.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA